Aptamer Sciences Inc
KOSDAQ:291650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptamer Sciences Inc
KOSDAQ:291650
|
KR |
|
Enterprise Diversified Inc
OTC:ENDI
|
US |
|
CSL Ltd
F:CSJA
|
AU |
|
C
|
CPI Europe AG
SWB:IMO1
|
AT |
|
CPI Europe AG
F:IMO1
|
AT |
Intrinsic Value
Is Aptamer Sciences Inc undervalued or overvalued?
See the intrinsic value estimate for Aptamer Sciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Aptamer Sciences Does
Aptamer Sciences Inc. is a biotechnology company that works with aptamers, which are short DNA or RNA molecules that can bind to specific targets much like antibodies do. The company develops aptamer-based materials and related research tools for use in diagnostics, biosensing, and life science research. It also works on custom aptamer discovery and design for customers that need a molecule to detect or capture a specific target.
- Headquarters
- Korea KR
- Employees
- 35
- IPO date
- Sep 16, 2020
Earnings Waterfall
Aptamer Sciences Inc
The intrinsic value for Aptamer Sciences Inc (291650) under the Base Case is hidden KRW.
Compared with the current market price of 2 470 KRW, the stock appears hidden.